| | | |   | | | | By Ed Silverman Adobe The issues regarding director compensation at Arrowhead Pharmaceuticals are "extremely rare,” said Aaron Wendt of Glass Lewis. Read More | | By Isabella Cueto Courtesy Ivan Kondratov/Enamine Suddenly, reading the latest published research, figuring out what chemical building blocks his team could synthesize, mattered little. Read More | | By Ed Silverman Adobe A watchdog group argues Lilly made "false assertions" that pausing some political contributions made an impact. Read More | | Sponsor content by ICON CLINICAL RESEARCH Advanced clinical solutions powered by healthcare intelligence — delivered seamlessly ICON is the world's largest and most comprehensive clinical research organization, powered by Healthcare Intelligence. Leveraging their human expertise, robust clinical capabilities, and insightful data resources, ICON is expanding the possibilities of clinical research without sacrificing the vital, day-to-day functions of today's CROs. Learn more. | | By Jonathan Wosen Adobe Element Biosciences announced the commercial launch of its new DNA sequencer — and with it, plans to rival industry behemoth Illumina. Read More | |
No comments